APART from non-pharmaceutical interventions (lockdowns or other restrictions) and vaccination, prophylaxis (treatment given or action taken to prevent disease or its severity) is another pathway to flatten the curve that, to date, has been given less attention than it deserves.
Vitamin D (VitD) - one of the central elements of our immune system, which is inexpensive and has a relatively safe side-effect profile molecule that is toxic only in extremely high doses - has captivated scientists’ interest as one potential prophylactic since the onset of the Covid-19 pandemic.